Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Leweke

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Molecular Psychiatry|October 17, 2007
Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissuesJ T-J Huang, L Wang, S Prabakaran, et al.
Molecular Psychiatry|February 22, 2012
Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophreniaJ M Coughlin, K Ishizuka, S I Kano, et al.
Molecular Psychiatry|January 26, 2010
Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patientsP C Guest, L Wang, L W Harris, et al.
Translational Psychiatry|August 2, 2017
Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophreniaG Kannan, K L Gressitt, S Yang, et al.
Molecular Psychiatry|April 13, 2011
Identification of a biological signature for schizophrenia in serumE Schwarz, P C Guest, H Rahmoune, et al.
Translational Psychiatry|July 15, 2015
Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onsetM K Chan, M-O Krebs, D Cox, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Molecular Psychiatry|October 17, 2007
Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissuesJ T-J Huang, L Wang, S Prabakaran, et al.
Molecular Psychiatry|February 22, 2012
Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophreniaJ M Coughlin, K Ishizuka, S I Kano, et al.
Molecular Psychiatry|January 26, 2010
Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patientsP C Guest, L Wang, L W Harris, et al.
Translational Psychiatry|August 2, 2017
Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophreniaG Kannan, K L Gressitt, S Yang, et al.
Molecular Psychiatry|April 13, 2011
Identification of a biological signature for schizophrenia in serumE Schwarz, P C Guest, H Rahmoune, et al.
Translational Psychiatry|July 15, 2015
Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onsetM K Chan, M-O Krebs, D Cox, et al.
Pageof 4